Johnson & Johnson’s COVID-19 Vaccine Receives Health Canada Approval for the Prevention of COVID-19 in Individuals Aged ≥18 years
Shots: The approval was based on the P-III (ENSEMBLE) study to evaluate the COVID-...
Pfizer and BioNTech’s Comirnaty Receive CHMP’s Positive Opinion for the Treatment of COVID-19 in Children Aged 5 To 12 Years
Shots: The CHMP opinion is based on...
Celltrions Regdanvimab Receives the ECs Approval for the Treatment of COVID-19
Shots: The EC has granted...
Regeneron Reports Results of REGEN-COV (casirivimab and imdevimab) in P-III Study Against COVID-19
Shots: The P-III trial ev...
